Navigation Links
Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
Date:10/29/2008

SAN MARINO, Calif., Oct. 29 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body. Clinical data from on-going studies in Los Angeles, California, indicating dose-dependent tumor control rates and survival benefits with no major toxicity in Rexin-G-treated patients prompted the extension of these clinical trials to the East Coast. Rexin-G has gained orphan drug status from the U.S. FDA for three clinical indications: pancreatic cancer, osteosarcoma and soft tissue sarcoma.

The New York clinical trials will be conducted at the Bruckner Oncology Center in Manhattan, New York with Howard W. Bruckner, M.D. as the Principal Investigator. Dr. Bruckner is a board certified medical oncologist who trained at Yale University School of Medicine and performed research at the NIH with specialists and collaborative groups. Dr. Bruckner is internationally renowned for his work in pancreatic, breast, gastrointestinal, colon, and ovarian cancers and was the first medical oncologist to treat patients with Rexin-G for advanced pancreatic cancer in the United States (Int'l J Oncol 2006). He has served as an Expert Consultant and Safety Monitor for the National Surgical Adjuvant Project for Breast and Bowel Cancers Project (NSABP) sponsored by the National Cancer Institute. For further information concerning these clinical trials in New York, please go to http://www.clinicaltrials.gov and search Epeius-sponsored protocols C07-104 and C07-105.

About Epeius Biotechnologies

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic
'/>"/>

SOURCE Epeius Biotechnologies Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
2. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
3. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
4. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
5. MEDICA 2008 Returns in November
6. NanoMedicine Summit Returns to Cleveland, September 25-26
7. Cystic Fibrosis Trial In Children Returns Positive Data
8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
9. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
10. Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment
11. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Diego, California (PRWEB) July 23, 2014 With ... second in HD resolution for more than 15 minutes, Fastec ... to the world of high speed imaging. “Finally, a high ... other camera we use in our everyday lives.” proclaims Matt ... at Fastec has always been to demystify and simplify the ...
(Date:7/23/2014)... MA (PRWEB) July 23, 2014 ... medicine transplant therapies are biological, but not magical. ... may seem to treat them as if they ... well as unsanctioned studies that constitute “stem cell ... as an approach to developing new regenerative medicine ...
(Date:7/22/2014)... July 22, 2014 The Board of Directors of ... has declared a quarterly dividend of 54.5 cents per common ... on September 9, 2014. The indicated annual dividend rate is ... BD is a leading medical technology company that partners with ... pressing and evolving health needs. Our innovative solutions are focused ...
(Date:7/22/2014)... of rod-shaped metal nanoparticles in water with ultrasound and ... bits. Why? No one yet knows exactly. But researchers ... have clocked their speedand it,s fast. At up to ... faster than any nanoscale object submerged in liquid ever ... opened up the possibility that they could be used ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... All Conditions to the Tender Offer Have Been Satisfied, ... and,Investments Ltd. (TASE: CII) announced today that all of ... to purchase,up to 2,338,686 ordinary shares of Fundtech Ltd. ... to the seller in cash, less any required,withholding taxes ...
... and employees in Massachusetts, encompassing over 250,000 square feet for ... ... CANTON, Mass., April 3, 2008 Joined by local officials,and Organogenesis, ... company, which was once,planning to move its operations outside of the ...
... DNDN ) today announced that it has entered into ... million shares of its,common stock and warrants to purchase ... gross proceeds of approximately $47 million, before,deducting placement agent ... The investor has agreed to purchase the,shares of common ...
Cached Biology Technology:Clal Industries Commences Additional Offer Period for Fundtech Tender Offer 2Clal Industries Commences Additional Offer Period for Fundtech Tender Offer 3Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 2Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 3Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 4Dendreon Announces $47 Million Registered Direct Offering 2Dendreon Announces $47 Million Registered Direct Offering 3
(Date:7/23/2014)... membrane degradation and blood-brain barrier damage appear ... brain functioning. Matrix metalloproteinase-9 is able to ... membrane around cerebral blood vessels and to ... Hou and colleagues from the First Affiliated ... University, China induced cerebral infarction in stroke-prone ...
(Date:7/23/2014)... German . ... of Molecular Cell Biology and Genetics in Dresden ... images of cardiac dynamics in zebrafish. The novel ... (SPIM) and clever image processing to reconstruct multi-view ... have developed a method of generating high-resolution static ...
(Date:7/22/2014)... professor with an expertise in big data and bioinformatics ... more than $600,000 to develop an interactive database of ... associate professor, will lead the project with professor Chris ... Engineering department. Scientists are compiling and studying data related ... involved in fruit fly development are commonly found in ...
Breaking Biology News(10 mins):Unbreak my heart 2UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... Society for Cell Biology is inviting the general public to ... Evening of Art & Science" at the Moscone Center in ... the public who sign up for free online at ... addresses by Stephen Chu, Nobel prize laureate and U.S. Secretary ...
... of Missouri researcher Mark Flinn, professor of anthropology, has ... Advancement of Science fellow for his "theoretical contributions in ... for pioneering field research on stress response, family environment, ... Election as a fellow of the ...
... the focus of an upcoming workshop at the Institute ... 29 November-1 December, 2012), according to the Malaysian Department ... Society. The gatheringthe first of its kind ... 60 participants, including stakeholders from the logging industry, oil ...
Cached Biology News:Public invited to 'An Evening of Science & Art' at ASCB Annual Meeting 2Cultural anthropologist Mark Flinn named 2013 AAAS Fellow 2Conservationists to create blueprint for saving Malaysia's elephants 2
Competitors to lower non-specific signal...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Biology Products: